InsidersTradesSigma
Track the NEOGENOMICS, INC. share price and the full insider trade history of the company, a listed issuer based in United States. Shares trade on the US market, under the oversight of SEC (Form 4). Market capitalisation: €2bn. The latest transaction was filed on 4 August 2026 (Notice of proposed sale (Form 144)). Among the most active insiders: GREG AUNAN. The full history is free.
3
Insider Decl.
n/a
Thresholds
n/a
n/a
Buy Volume
n/a
n/a
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate NEOGENOMICS, INC. Strong Buy (bullish), based on 12 analysts. Average price target: US$58.59.
26Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 25,032 of 28,836 companies
25.1
score / 100
Value24
Quality26
FCF yld-3.8%
Earn yld-4.8%
EV/EBITDA·
ROE-40%
Gross mgn43%
Net mgn-18%
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 4 August 2026
Declarations3 total
20,000 shares@ US$16.074CommonSEC144:0001950047-26-007613
236,876 shares@ US$15.63920.19% mcap100.0% of flowCommonSEC144:0001950047-26-007427
5,307 shares@ US$11.15100.0% of flowCommonSEC144:0001950047-26-006094
3 of 3 declarations
About NEOGENOMICS, INC.
NEOGENOMICS, INC. is a company specializing in genetic testing and diagnostic services for the healthcare sector. It is listed on the NASDAQ under the symbol NEOG.